Kazia Therapeutics
$5.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.13 (+49.88%) Today
-$0.87 (-13.59%) As of 7:42 AM EDT after-hours
Why Robinhood?
You can buy or sell KZIA and other stocks, options, ETFs, and crypto commission-free!
About KZIA
Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil. Read More The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
CEO
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1994
Market Cap
60.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.23M
High Today
$8.13
Low Today
$5.83
Open Price
$7.68
Volume
21.26M
52 Week High
$9.74
52 Week Low
$2.27